Učitavanje...
Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review
BACKGROUND: The emergence of immune checkpoint inhibitors (ICIs) has brought about a paradigm shift in cancer treatment as the use of these drugs has become more frequent and for a longer duration. As a result of T-cell-mediated inflammation at the programmed cell death-1, programmed death-ligand-1,...
Spremljeno u:
| Izdano u: | Cardiooncology |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8259377/ https://ncbi.nlm.nih.gov/pubmed/34229760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40959-021-00112-z |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|